Diseases, Conditions, Syndromes

How omicron escapes from antibodies

A new study from MIT suggests that the dozens of mutations in the spike protein of the omicron variant help it to evade all four of the classes of antibodies that can target the SARS-CoV-2 virus that causes COVID-19.

Diseases, Conditions, Syndromes

Experimental and computational synergy—Promising COVID-19 results

An international collaboration between researchers from the Center for Cooperative Research in Biosciences (CIC bioGUNE, Bilbao), the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourgand and ...

Vaccination

Predicting how well a vaccine will work for you

In an advance that sheds light on why certain vaccines may influence people differently, a new computational approach developed at the University of Michigan may predict how individual patients are likely to respond.

Oncology & Cancer

MicroRNA exhibit unexpected function in driving cancer

Researchers long thought that only one strand of a double-stranded microRNA can silence genes. Though recent evidence has challenged that dogma, it's unclear what the other strand does, and how the two may be involved in ...

Diseases, Conditions, Syndromes

Study pinpoints new drug targets to treat Nipah virus

Nipah virus, which is transmitted to humans from bats and pigs, has a high mortality rate and there are no licensed drugs against it. Now, researchers have used information on the structure of the Nipah virus to identified ...

page 3 from 5